Temler R S, Simon E, Amiguet P
Enzyme. 1983;30(2):105-14. doi: 10.1159/000469558.
The present work describes the effect of two soya bean protease inhibitors: Kunitz type (SBTI) and Bowman-Birk type (BBTI) on rat trypsin I (TrI), trypsin II (TrII) and chymotrypsin (Chtr) and on human cationic trypsin (hTr). The inhibition spectra show that: (1) SBTI inhibits TrI, TrII, Chtr and hTr esterase activities by 80, 80, 83 and 45%, respectively, at inhibitor-to-enzyme molar ratios of one-to-one, and (2) BBTI inhibits TrI, TrII, Chtr, and hTr esterase activities by 50, 65, 75 and 30%, respectively, at an inhibitor-to-enzyme molar ratio of two-to-one. A similar inhibition pattern was obtained by testing proteolytic activities. It would appear that hTr is less sensitive to soya bean protease inhibitors than each of the rat proteases investigated. This difference in inhibition should be considered when a rat is used as a model to predict the effects of dietary soya bean protease inhibitors on humans.
库尼兹型(SBTI)和鲍曼-伯克型(BBTI)对大鼠胰蛋白酶I(TrI)、胰蛋白酶II(TrII)、糜蛋白酶(Chtr)以及对人阳离子胰蛋白酶(hTr)的作用。抑制谱表明:(1)在抑制剂与酶的摩尔比为1:1时,SBTI分别抑制TrI、TrII、Chtr和hTr酯酶活性的80%、80%、83%和45%;(2)在抑制剂与酶的摩尔比为2:1时,BBTI分别抑制TrI、TrII、Chtr和hTr酯酶活性的50%、65%、75%和30%。通过测试蛋白水解活性也获得了类似的抑制模式。似乎hTr对大豆蛋白酶抑制剂的敏感性低于所研究的每种大鼠蛋白酶。当使用大鼠作为模型来预测膳食大豆蛋白酶抑制剂对人类的影响时,应考虑这种抑制差异。